Skip to main content
. 2014 Jan 17;53(5):890–899. doi: 10.1093/rheumatology/ket475

Table 3.

Risk factors for rheumatoid vasculitis among patients with RA seen at the Mayo Clinic (Rochester, MN, USA), 2000–10

Cases (n = 86) Controls (n = 172) Odds ratio (95% CI)
Sex, male 36 (42) 53 (31) 1.72 (0.98, 3.00)
Age at RA diagnosis, mean (s.d.), years 47.7 (14.5) 52.4 (13.4) 0.98 (0.97, 0.99)
BMI, mean (s.d.), kg/m2 27.1 (5.5) 27.6 (5.2) 1.00 (0.94, 1.06)
Current smoker at RA diagnosis 34 (40) 39 (23) 1.98 (1.10, 3.56)
Rheumatoid nodules 38 (44) 45 (26) 1.49 (0.80, 2.78)
Radiographic erosions 46 (54) 66 (39) 1.38 (0.78, 2.43)
Any joint surgery 30 (35) 37 (22) 1.23 (0.62, 2.44)
Any erosions, nodulosis and/or joint surgery 62 (72) 84 (49) 2.02 (1.1, 3.71)
Rheumatoid lung disease 9 (10) 11 (6) 1.59 (0.60, 4.21)
SS 8 (9) 18 (11) 0.85 (0.34, 2.10)
C-spine disease 10 (12) 6 (4) 2.03 (0.66, 6.24)
Rheumatoid pericarditis 6 (7) 4 (2) 2.67 (0.72, 9.96)
≥2 extra-articular manifestations 7 (8) 2 (1) 5.05 (0.98, 26.06)
Positive RF 72 (84) 137 (82) 0.80 (0.38, 1.67)
Positive ACPA 30 (67) 31 (51) 1.88 (0.80, 4.40)
Positive ANA 24 (29) 24 (19) 1.93 (0.96, 3.89)
Hypertension 39 (45) 62 (36) 1.63 (0.91, 2.92)
Hyperlipidaemia 25 (29) 47 (28) 1.29 (0.69, 2.40)
Diabetes mellitus 12 (14) 15 (9) 1.79 (0.77, 4.12)
Cardiovascular disease 12 (14) 23 (14) 0.90 (0.40, 2.04)
Peripheral vascular disease 9 (10) 4 (2) 3.98 (1.14, 13.99)
Cerebrovascular disease 14 (16) 5 (3) 6.48 (2.11, 19.97)
Atrial fibrillation 3 (4) 6 (4) 0.83 (0.19, 3.65)
Venous thromboembolism 8 (9) 8 (5) 2.23 (0.79, 6.32)
MTX for RA 58 (69) 121 (70) 0.69 (0.37, 1.28)
HCQ for RA 30 (37) 85 (51) 0.54 (0.31, 0.94)
≥3 DMARDs for RA 25 (29) 27 (16) 1.57 (0.81, 3.04)
Biologic use for RA 34/81 (42) 26/170 (15) 2.80 (1.50,5.23)
Low-dose aspirin 15 (17) 50 (29) 0.42 (0.21,0.85)
Statins 19 (22) 34 (20) 1.36 (0.69,2.68)

Values are n (%) unless indicated otherwise. Statistically significant variables are shown in bold.